Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.56 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | ANPEP | P15144 | 3/20 | 0.48 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.48 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.44 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | TDO2 | P48775 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4895850 | 0.91 | EPHX1 (0.56) | HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL9367447 | 0.88 | MAOA (0.57) | HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL19143919 | 0.85 | TDP1 (0.54) | HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL3442080 | 0.84 | HTR2A (0.52) | HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL11805109 | 0.84 | S1PR2 (0.62) | HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL4890813 | 0.84 | MAOA (0.59) | HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1 | |
| Hydrochloric Acid SCHEMBL10436202 | 0.83 | MAOA (0.57) | HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL19295552 | 0.82 | SMN1; SMN2 (0.42) | HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1 | |
| SCHEMBL172466 | 0.81 | S1PR1 (0.49) | TAAR1MAOAANPEPERAP1ERAP2 | |
| SCHEMBL8599042 | 0.81 | ANPEP (0.50) | HTR2ALOXL2CYP2A6SMN1; SMN2TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109928867-B | Method for synthesizing 3, 5-dihydroxyl pentylbenzene | 江苏暨明医药科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | claimed |
| CN-112939738-B | Preparation method of 3, 5-dihydroxypentylbenzene | 杭州凯方科技有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-109928867-B | Method for synthesizing 3, 5-dihydroxyl pentylbenzene | 江苏暨明医药科技有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-109928867-B | Method for synthesizing 3, 5-dihydroxyl pentylbenzene | 江苏暨明医药科技有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-112939738-A | Preparation method of 3, 5-dihydroxypentylbenzene | 杭州凯方科技有限公司 | 2021-06-11 | — | — | CN | disclosed |
| CN-111393265-A | Synthetic method of 3, 5-dihydroxypentylbenzene | 安徽中羰碳一工业技术有限责任公司 | 2020-07-10 | — | — | CN | disclosed |
| US-9376553-B2 | Organic-inorganic composite molded product and optical element | CANON KABUSHIKI KAISHA (JP) | 2016-06-28 | — | — | US | disclosed |
| US-20140142229-A1 | ORGANIC-INORGANIC COMPOSITE MOLDED PRODUCT AND OPTICAL ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2014-05-22 | — | — | US | disclosed |
| WO-2012172736-A1 | ORGANIC-INORGANIC COMPOSITE MOLDED PRODUCT AND OPTICAL ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2012-12-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | HTR2A 439/4885LOXL2 4742/4885CYP2A6 2818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.